Growth Leap
Growth Leap
Stun and Awe
Playing with Light and AI: iLoF's Answer to Personalized Medicine
42 minutes Posted Feb 21, 2024 at 2:00 pm.
Understanding iLoF and Personalized Medicine
Data and iLoF's Approach to Personalized Medicine
400 Failed Clinical Trials and the Importance of Patient Selection
Apply the Netflix' Personalization Model to Clinical Trial
The Only Reason You Should Start a Deep Tech Company According to Luis
How Luis Started a Deep Tech Startup
How Luis Did 10 Interviews a Week for 10 Weeks to Validate a Problem at the Harvard/MIT Accelerator
How to Position Your Startup in a Highly Regulated Industry
iLof's Business Model and 'Foot on the Door' Strategy
The Harduous path for Alzheimer's Patient Selection in Trials
How Successful is iLof's Technology
What Keeps Luis Awake at Night
Fundraising and Investor Relations
Future Plans and Goals for the Next 12 Months
0:00
42:32
Download MP3
Show notes
Send a text I had the incredible opportunity to sit down with Luis Valente, the CEO and co-founder of iLoF, for an enlightening conversation about his journey in the deep tech world and the pioneering work iLoF is doing in personalized medicine. Luis, who has been honored in the Forbes 30 under 30 list, shared the story behind iLoF, a company at the forefront of using AI to transform our approach to treating complex diseases. During our chat, Luis opened up about the passion driving him and ...